Molecular Insights into Fully Human and Humanized Monoclonal Antibodies: What are the Differences and Should Dermatologists Care?

Autor: Mallbris, Lotus, Davies, Julian, Glasebrook, Andrew, Tang, Ying, Glaesner, Wolfgang, Nickoloff, Brian J.

In recent years, a large number of therapeutic monoclonal antibodies have come to market to treat a variety of conditions including patients with immune-mediated chronic inflammation. Distinguishing the relative clinical efficacy and safety profiles

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::526be87ade94ed15321bdcdce4fbc670
https://europepmc.org/articles/PMC5022998/

Glycosylation of Erythropoietin Affects Receptor Binding Kinetics: Role of Electrostatic Interactions.

Autor: Darling, Ryan J., Kuchibhotla, Uma, Glaesner, Wolfgang, Micanovic, Radmila, Witcher, Derrick R., Beals, John M.

Publikováno v: Biochemistry; 12/10/2002, Vol. 41 Issue 49, p14524, 8p, 4 Charts, 5 Graphs

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Molecular Insights into Fully Human and Humanized Monoclonal Antibodies: What are the Differences and Should Dermatologists Care?

Autor: Mallbris L; Eli Lilly and Company, Indianapolis, Indiana., Davies J; Eli Lilly and Company, Indianapolis, Indiana., Glasebrook A; Eli Lilly and Company, Indianapolis, Indiana., Tang Y; Eli Lilly and Company, Indianapolis, Indiana., Glaesner W; Eli Lilly and Company, Indianapolis, Indiana., Nickoloff BJ; Eli Lilly and Company, Indianapolis, Indiana.

Publikováno v: The Journal of clinical and aesthetic dermatology [J Clin Aesthet Dermatol] 2016 Jul; Vol. 9 (7), pp. 13-5. Date of Electronic Publication: 2016 Jul 01.